Search for: "Ely Lilly" Results 301 - 320 of 2,173
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Dec 2018, 4:55 am
| Book Review: Kerly’s Law of Trade Marks and Trade Names | Thursday Thingies | Around the IP BlogsNever Too Late 204 [Week ending 28 Oct] Court of Appeal reaffirms UK as SEP litigation hotspot in upholding Birss J in Unwired Planet | Much Ado About FRAND: What you need to know about today's Court of Appeal Unwired Planet decision | AIPPI UK Rapid Response Event: Unwired Planet v Huawei - 13 November at 6PM | Lord Kitchin applies the "markedly different" infringement… [read post]
7 Dec 2018, 2:23 pm by Lawrence B. Ebert
”AbbVie, 764 F.3d at 1372 (citing Eli Lilly & Co. v. [read post]
7 Dec 2018, 3:00 am by John Jenkins
According to the study, they include GE, Intel, Pfizer, Allstate, Medtronic, Eli Lilly, Southwest Airlnes, AEP, Ingersoll Rand, Praxair, Entergy, Clorox, NiSource & Dentsply Sirona. [read post]
27 Nov 2018, 3:19 am
Image Credits: In NYCPREVIOUSLY ON NEVER TOO LATENever Too Late 204 [Week ending 28 Oct] Court of Appeal reaffirms UK as SEP litigation hotspot in upholding Birss J in Unwired Planet | Much Ado About FRAND: What you need to know about today's Court of Appeal Unwired Planet decision | AIPPI UK Rapid Response Event: Unwired Planet v Huawei - 13 November at 6PM | Lord Kitchin applies the "markedly different" infringement approach in Actavis v Eli Lilly in… [read post]
21 Nov 2018, 12:04 pm
 We begin this week with an update on the pemetrexed (Alimta) Italian patent case between Fresenius Kabi and Eli Lilly.Pemetrexed disodium at the Court of MilanLast year, IPKat blogged about the Court of Milan's decision in the pemetrexed (Alimta) patent case (Court of Milan, 12 September 2017, urgent proceedings between Fresenius Kabi and Eli Lilly).That decision has now been fully reversed by a panel of three judges of the same Court of… [read post]
21 Nov 2018, 12:00 am by Alexa von Uexküll
Alexa von Uexküll and Oswin RidderbuschOver the past few years the pan-European and parallel national patent litigation based on Eli Lilly’s pemetrexed patent has attracted considerable attention, as it has resulted in a number of diverse land mark decisions in relation to the doctrine of equivalence, as evidenced by the various posts in this blog. [read post]
18 Nov 2018, 7:39 am
 In her comment Lord Kitchin applies the "markedly different" infringement approach in Actavis v Eli Lilly in Icescape v Ice-World, InternKat Rose analyses this recent case to determine whether Lord Kitchin approached any of the unresolved issues left in the Actavis v Eli Lilly case.CopyrightLast year The IPKat reported on two new important referrals to the Court of Justice of the European Union (CJEU) from Germany. [read post]
1 Nov 2018, 6:26 am by Robert Kraft
The warning applies to the class of SGLT2 inhibitors, specifically, Johnson & Johnson’s Invokana (canagliflozin), AstraZeneca Plc’s Farxiga (dapagliflozin), and Eli Lilly & Co. [read post]
24 Oct 2018, 3:49 am
Since the landmark UK Supreme Court decision in Actavis v Eli Lilly ([2017] UKSC 48), judges of the lower courts have voiced the need for clarification from the Supreme Court. [read post]
17 Oct 2018, 8:28 am by Brian Cordery
The Court therefore gave consideration to what Lord Kitchin denoted the “Actavis questions” further to the Supreme Court decision in Actavis v Eli Lilly. [read post]
17 Oct 2018, 8:16 am by Lindsay Offutt
Minnesota Attorney General Lori Swanson filed a lawsuit Tuesday in the US District Court for the District of New Jersey alleging insulin manufacturers Sanofi-Aventis US, Novo Nordisk and Eli Lilly deceptively raised insulin prices. [read post]
16 Oct 2018, 12:20 pm by Steve Brachmann
The last case was a summary affirmance of a victory by German drugmaker Erfindergemeinschaft UroPep over Eli Lilly in the Eastern District of Texas. [read post]
11 Oct 2018, 12:57 am by Eszter Szakács
Here the court agreed with MSD’s appeal in that the HIPO’s interpretation of the Eli Lilly judgment was wrong: it does not follow from this judgment that the concerned active ingredient should be mentioned by name or by structure in the description. [read post]
29 Sep 2018, 8:09 pm by Patent Docs
True Health Diagnostics LLC -- Eli Lilly & Co. v. [read post]
18 Sep 2018, 2:23 am
When Sky v SkyKick leaves rightsholders in limbo | The Intellectual Property Owners Association | Report on IPO’s 2018 European Practice Committee Conference (1/2) |  Book review: Propertizing European Copyright – History, Challenges and Opportunities |  GDPR notification | Thursday Thingies | Around the IP Blogs.Never Too Late 194 [weeks ending 13th and 20th May] Important amendments under Mexican law regarding patents, utility models and industrial… [read post]
10 Sep 2018, 1:25 am by Kluwer Patent Blog
’“ 3) International Investment Arbitration, the European Patent Office, and the Future Unified Patent Court by Thomas Musmann “Since the Eli Lilly v. [read post]
10 Sep 2018, 1:20 am by Kluwer Patent blogger
’“ 3) International Investment Arbitration, the European Patent Office, and the Future Unified Patent Court by Thomas Musmann “Since the Eli Lilly v. [read post]